TrialJournal of clinical pharmacology2023

Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.

Hwa-Ping Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.